---
title: Historical legal status of psychedelics
videoId: fpwDi8f6TLQ
---

From: [[⁨cleoabram⁩]] <br/> 

The legal status of psychedelics has undergone significant shifts throughout history, moving from initial legality and promising medical research to a period of prohibition and, more recently, a renewed push for legalization and scientific exploration <a class="yt-timestamp" data-t="00:01:05">[00:01:05]</a>.

## Early Legality and Medical Promise

In 1955, psychedelics were legal in both the United Kingdom and the United States <a class="yt-timestamp" data-t="00:00:40">[00:00:40]</a>. During this period, they were considered an exciting area of medical research <a class="yt-timestamp" data-t="00:00:45">[00:00:45]</a>. Companies even sent drugs like LSD directly to doctors for experimental use <a class="yt-timestamp" data-t="00:04:40">[00:04:40]</a>.

## The [[war_on_drugs_and_its_impact_on_psychedelic_research | War on Drugs]] and Prohibition

By the 1980s, the landscape had drastically changed <a class="yt-timestamp" data-t="00:00:48">[00:00:48]</a>. The United States declared a "War on Drugs" <a class="yt-timestamp" data-t="00:00:54">[00:00:54]</a>, leading to the banning of psychedelics and a darker turn for related research <a class="yt-timestamp" data-t="00:00:56">[00:00:56]</a>. For approximately 40 years, most psychedelics remained illegal <a class="yt-timestamp" data-t="00:00:59">[00:00:59]</a>.

This shift was largely sociopolitical rather than purely scientific <a class="yt-timestamp" data-t="00:05:36">[00:05:36]</a>. Psychedelics became heavily associated with the counter-culture movement of the 1960s, leading them to be "forbidden" even for legitimate researchers <a class="yt-timestamp" data-t="00:05:43">[00:05:43]</a>. Research conducted during this era often supported the government's narrative that psychedelics were extremely dangerous, solidifying public opinion against them <a class="yt-timestamp" data-t="00:05:53">[00:05:53]</a>. However, it is now known that not all research from this period was accurate, such as a prominent study that mistakenly injected monkeys with meth instead of ecstasy, leading to highly publicized, yet false, claims of permanent brain damage from ecstasy <a class="yt-timestamp" data-t="00:06:03">[00:06:03]</a>. This historical framing significantly influenced public perception for decades <a class="yt-timestamp" data-t="00:07:12">[00:07:12]</a>.

## Current Re-evaluation and Legalization Efforts

Currently, the tide is changing once again <a class="yt-timestamp" data-t="00:01:05">[00:01:05]</a>, with a new and growing movement to legalize psychedelics in the United States <a class="yt-timestamp" data-t="00:01:17">[00:01:17]</a>. They are once more becoming an intriguing area of study <a class="yt-timestamp" data-t="00:01:20">[00:01:20]</a>, particularly due to suggestions of major [[potential_health_benefits_and_therapeutic_applications_of_psychedelics | health benefits and therapeutic applications]] <a class="yt-timestamp" data-t="00:01:24">[00:01:24]</a>.

This renewed interest is driven by promising [[current_research_and_scientific_understanding_of_psychedelics | new research]] <a class="yt-timestamp" data-t="00:07:32">[00:07:32]</a>. For example, psilocybin has shown potential to relieve anxiety and depression in cancer patients <a class="yt-timestamp" data-t="00:07:46">[00:07:46]</a>, and MDMA has been effective in treating PTSD <a class="yt-timestamp" data-t="00:07:54">[00:07:54]</a>. If these findings prove consistently true, it would suggest a significant misclassification of these drugs in the past <a class="yt-timestamp" data-t="00:01:33">[00:01:33]</a>.

### Models for Legal Access

The current debate around [[psychedelic_legalization_and_regulation_debate | psychedelic legalization and regulation debate]] focuses primarily on supervised settings rather than recreational, unsupervised use, which differs from the approach taken with cannabis <a class="yt-timestamp" data-t="00:10:45">[00:10:45]</a> <a class="yt-timestamp" data-t="00:11:10">[00:11:10]</a>.

Two main models are under consideration:

*   **FDA-Approved Medical Use**: This model envisions doctors prescribing MDMA and psilocybin, with licensed therapists supervising the "trip" in certified clinics <a class="yt-timestamp" data-t="00:11:15">[00:11:15]</a> <a class="yt-timestamp" data-t="00:11:21">[00:11:21]</a>. MDMA could potentially be approved by the FDA for PTSD within a year or two, followed by psilocybin approval a few years later <a class="yt-timestamp" data-t="00:10:24">[00:10:24]</a>.
*   **State-Level Legalization in Supervised Settings**: States like Oregon and Colorado have legalized psilocybin for use in "healing centers," where individuals can take the substance under the supervision of a facilitator (not necessarily a doctor) <a class="yt-timestamp" data-t="00:12:03">[00:12:03]</a> <a class="yt-timestamp" data-t="00:12:13">[00:12:13]</a>. While these centers are not yet open, the vision remains one of supervised use <a class="yt-timestamp" data-t="00:12:18">[00:12:18]</a>.

The overarching goal is to base regulation on robust science, avoiding unwarranted fear or hype <a class="yt-timestamp" data-t="00:12:42">[00:12:42]</a>. The [[historical_perspectives_on_groundbreaking_ideas_and_innovation | history]] of psychedelics serves as a cautionary tale of trying to control what is not fully understood, leading to decades of stifled innovation <a class="yt-timestamp" data-t="00:12:51">[00:12:51]</a>. The renewed, more measured approach aims to potentially help millions struggling with health conditions <a class="yt-timestamp" data-t="00:13:13">[00:13:13]</a>.